Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00612768 · ClinicalTrials.gov registry record · Phase 2
Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations
A Phase 2 study, sponsored by Allerderm.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00612768 is a Phase 2 study that has completed, run by Allerderm. The registered enrollment target is 50 participants.
The verdict
NCT00612768, a Phase 2 study, has completed, sponsored by Allerderm.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
Open, prospective, multi-center study to evaluate the bioequivalence of povidone (PVP) formulations of 2 T.R.U.E. TEST allergens: fragrance mix and thimerosal.
Interventions
- BIOLOGICAL TRUE Test allergens Fragrance Mix and Thimerosol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00612768
The ClinicalTrials.gov registry entry for NCT00612768 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allerderm, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TRUE Test allergens Fragrance Mix and Thimerosol is the first listed.
NCT00612768 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00612768 about?
NCT00612768 is a clinical study titled "Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations". Open, prospective, multi-center study to evaluate the bioequivalence of povidone (PVP) formulations of 2 T.R.U.E. TEST allergens: fragrance mix and thimerosal.
What is the current status of trial NCT00612768?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2008-01. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00612768?
The interventions under investigation include: TRUE Test allergens Fragrance Mix and Thimerosol (BIOLOGICAL).
Who is sponsoring clinical trial NCT00612768?
This trial is sponsored by Allerderm, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.